Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases (Q35607764)

9 August 2017

1 reference

title

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases (English)

1 reference

9 August 2017

1 reference

11

Karen H Lu

1 reference

9 August 2017

10

David M Gershenson

1 reference

9 August 2017

1

Brian M Slomovitz

1 reference

9 August 2017

Thomas W Burke

2

1 reference

9 August 2017

Patricia J Eifel

3

1 reference

9 August 2017

Lois M Ramondetta

4

1 reference

9 August 2017

Elvio G Silva

5

1 reference

9 August 2017

Anuja Jhingran

6

1 reference

9 August 2017

Jonathan C Oh

7

1 reference

9 August 2017

E Neely Atkinson

8

1 reference

9 August 2017

Russell R Broaddus

9

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

91

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

463-469

1 reference

9 August 2017

cites work

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Uterine papillary serous carcinoma: patterns of metastatic spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Uterine serous papillary carcinoma: histopathologic changes within the female genital tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

BRCA1 germline mutations in women with uterine serous papillary carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Early uterine serous carcinoma: clonal origin of extrauterine disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Uterine papillary serous carcinoma: study of 19 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Stage IA uterine serous carcinoma: a study of 13 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

The treatment of uterine papillary serous carcinoma (UPSC): are we doing the right thing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Noninvasive papillary serous carcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Treatment of uterine papillary serous carcinoma with paclitaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.08.018

10.1016/J.YGYNO.2003.08.018

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference